Protocol for pooled FACS-based CRISPR knockout screening in human iPSC-derived microglia
Here, we present a protocol for CRISPR knockout screening in human induced pluripotent stem cell (hiPSC)-derived microglia (iMGL) using lentiviral delivery of CRISPR-Cas9 and co-transduction of VPX virus-like particles (VPX-VLPs). We first describe large-scale production of iMGL from hiPSCs, production of the lentiviral and VPX-VLP libraries, and titration. Next, we describe how to perform a pooled CRISPR screen for phagocytosis including the computational analysis pipeline of CRISPR screening data. For complete details on the use and execution of this protocol, please refer to Perez-Alcantara et al.<sup>1</sup>.
Authors
- Andrew Bassett (ORCID: https://orcid.org/0000-0003-1632-9137)
- Sam Washer (ORCID: https://orcid.org/0000-0003-4004-8984)
- Elena Navarro‐Guerrero (ORCID: https://orcid.org/0000-0001-8076-1480)
- Sally A. Cowley (ORCID: https://orcid.org/0000-0003-0297-6675)
- Daniel V. Ebner (ORCID: https://orcid.org/0000-0002-6495-7026)
Institutions
- Discovery Centre (CA)
- Wellcome Sanger Institute (GB)
- University of Oxford (GB)
- Open Targets (GB)
Publication Details
- Journal
- STAR Protocols
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1016/j.xpro.2025.104111
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00